Somatosensation Device Trial
Testing of the Somatosensation Device (SD) for Device Effectiveness While Enhancing Feedback in Lower Extremities
1 other identifier
interventional
12
1 country
1
Brief Summary
This research is being done to test a new device, called the Somatosensation Device, with people who have either a below knee amputation, or neuropathy (i.e. decreased sensation) in their legs. When people have lost sensation in their feet, it may make walking and balance more difficult. The Somatosensation Device is designed to substitute the loss of feeling in a foot by pressing on nerves on the surface of the leg. It presses on the nerves by using a pneumatic balloon to put pressure on your skin. If people receive this extra sensation feedback, it may help improve their walking and balance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2023
CompletedFirst Posted
Study publicly available on registry
December 13, 2023
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedDecember 4, 2024
December 1, 2024
2 months
November 22, 2023
December 2, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Functional Gait Assessment (FGA)
The Functional Gait Assessment is a test to assess an individual's postural stability and ability to perform multiple motor tasks while walking. Tests include walking at different speeds, walking with head turns, turns, stepping over obstacles, walking tandem, walking with eyes closed, walking backwards, and stair navigation. Scores are on a 0-30 scale, with higher scores showing better balance and mobility.
Baseline, during the intervention
Secondary Outcomes (4)
10 Meter Walk Test
Baseline, during the intervention
Mini-BESTest
Baseline, during the intervention
Activities Specific Balance Confidence Scale (ABC)
Baseline, during the intervention
Vestibular Disorders Activities of Daily Living Scale (VADL)
Baseline, during the intervention
Study Arms (2)
Baseline (Without Somatosensation Device)
ACTIVE COMPARATORParticipants will perform all outcome measures without wearing the somatosensation device.
With Somatosensation Device
EXPERIMENTALParticipants will perform all outcome measures while wearing the somatosensation device.
Interventions
The somatosensation device will be worn on the lower limb (either the residual limb for an amputee, or limb with decreased sensation for a participant with diabetic neuropathy) while performing outcome measures.
Participants will perform outcome measures without wearing the somatosensation device.
Eligibility Criteria
You may qualify if:
- Have a below-knee amputation (either unilateral or bilateral) or neuropathy in their lower limbs.
- Ability to wear the somatosensation device on their lower limbs
- Ability to wear test equipment and heart rate monitors.
- Ability to follow simple directions.
You may not qualify if:
- History of severe back pain in the last 3 months.
- History of severe knee pain in the last 3 months.
- Unable to walk for 3 minutes with or without an assistive device
- Poor skin integrity (i.e open wounds, skin breakdown) that could be made worse by wearing the somatosensation device.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shirley Ryan AbilityLab
Chicago, Illinois, 60611, United States
MeSH Terms
Interventions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
November 22, 2023
First Posted
December 13, 2023
Study Start
March 1, 2024
Primary Completion
April 30, 2024
Study Completion
May 1, 2024
Last Updated
December 4, 2024
Record last verified: 2024-12